PPAR-Alpha Agonist Fenofibrate Combined with Octreotide Acetate in the Treatment of Acute Hyperlipidemia Pancreatitis

Table 3

Statistical analysis of complications during treatment of two groups of patients (, %).

Group	Number ()	Adverse complications	No adverse complications	Adverse complications rate
Observation group	30	4	26	13.33
Control group	30	6	24	20.00
value				0.48
value				0.488